Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Lexaria Corp (LXRP)

Lexaria Corp (LXRP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 20,148
  • Shares Outstanding, K 89,587
  • Annual Sales, $ 380 K
  • Annual Income, $ -4,080 K
  • 60-Month Beta N/A
  • Price/Sales 58.59
  • Price/Cash Flow N/A
  • Price/Book 8.12
Trade LXRP with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.01
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 01/13/21
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2135 +5.34%
on 01/11/21
0.3300 -31.85%
on 12/14/20
-0.0591 (-20.81%)
since 12/11/20
3-Month
0.1700 +32.29%
on 11/02/20
0.3500 -35.74%
on 12/04/20
-0.0347 (-13.37%)
since 10/09/20
52-Week
0.1700 +32.29%
on 11/02/20
0.5600 -59.84%
on 01/23/20
-0.2151 (-48.89%)
since 01/10/20

Most Recent Stories

More News
Lexaria Bioscience Corp. (NASDAQ: LEXX) Emerging as Leader in Pursuit of More-Effective Hypertension Treatment

NEW YORK, Sept. 16, 2021 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Lexaria Bioscience Corp. (NASDAQ: LEXX) announces the availability of a broadcast titled, “Hypertension: The Silent Killer Making...

LXRP : 0.2249 (-10.68%)
LXX.CN : 8.400 (-1.18%)
LEXX : 3.24 (+12.77%)
Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Throw Hat into Hypertension Ring with Proprietary Drug-Delivery System

NEW YORK, Sept. 15, 2021 (GLOBE NEWSWIRE) -- via InvestorWire — Lexaria Bioscience Corp. (NASDAQ: LEXX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"),...

LXRP : 0.2249 (-10.68%)
LXX.CN : 8.400 (-1.18%)
LEXX : 3.24 (+12.77%)
Lexaria Bioscience Corp. (NASDAQ: LEXX) on Forefront of Exciting Hypertension Innovation

NEW YORK, Aug. 06, 2021 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Lexaria Bioscience Corp. (NASDAQ: LEXX) announces the availability of a broadcast titled, “Cardiovascular Disease Drug Market Offers...

LXRP : 0.2249 (-10.68%)
LXX.CN : 8.400 (-1.18%)
LEXX : 3.24 (+12.77%)
Lexaria Bioscience Corp. (NASDAQ: LEXX) Leads the Way in Innovating Hypertension Treatment

NEW YORK, Aug. 04, 2021 (GLOBE NEWSWIRE) -- via InvestorWire — Lexaria Bioscience Corp. (NASDAQ: LEXX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"),...

LXRP : 0.2249 (-10.68%)
LXX.CN : 8.400 (-1.18%)
LEXX : 3.24 (+12.77%)
Proactive North America headlines including Lexaria Bioscience, LeanLife Health, Planet 13 Holdings and Fidelity Minerals

New York, April 22, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies:

TOMDF : 0.0318 (+6.35%)
LUKEF : 0.0652 (-1.21%)
CPKF : 26.0000 (+1.56%)
WMG : 29.97 (+0.27%)
FMN : 11.74 (+0.17%)
SAIDF : 0.0742 (+4.95%)
SFET : 0.5305 (-3.53%)
BLGO : 0.1770 (-2.85%)
GMBL : 0.6000 (+31.98%)
VEGA.CN : 0.030 (unch)
PLTXF : 0.0235 (-2.08%)
SWISF : 0.2089 (-0.05%)
Proactive news headlines including Lexaria Bioscience, ImagineAR, Blackrock Gold, Tetra Bio-Pharma and District Metals Corp

Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies:

LXX.CN : 8.400 (-1.18%)
LXRP : 0.2249 (-10.68%)
IP.CN : 0.070 (-6.67%)
IPNFF : 0.0600 (+5.26%)
BRC : 48.99 (+1.03%)
TBPMF : 0.0517 (-6.68%)
MTRX : 5.77 (+5.10%)
RACMF : 1.2400 (-0.80%)
MKVNF : 0.0900 (+0.78%)
AREC : 2.56 (-1.54%)
REX : 33.16 (+0.76%)
CYRTF : 0.8501 (+0.16%)
Lexaria Bioscience Corp. Announces Uplisting to Nasdaq Capital Market and Pricing of $9.6 Million Upsized Public Offering

KELOWNA, BC / ACCESSWIRE / January 12, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the "Company") today announced that its common stock and warrants will begin trading on the...

LXRP : 0.2249 (-10.68%)
LEXX : 3.24 (+12.77%)
LEXXW : 0.8541 (+20.30%)
LXX.CN : 8.400 (-1.18%)
Lexaria Announces Effective Date for Reverse Stock Split

KELOWNA, BC / ACCESSWIRE / January 8, 2021 / Lexaria Bioscience Corp. (OTCQX:LXRP)(CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, today announced that it intends...

LXRP : 0.2249 (-10.68%)
LXX.CN : 8.400 (-1.18%)
Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) Featured in Virtual Coverage of the LD Micro Main Event

Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) is a global innovator in drug delivery platforms. Its patented DehydraTECH(TM) drug delivery technology changes the way active pharmaceutical ingredients...

LXRP : 0.2249 (-10.68%)
LXX.CN : 8.400 (-1.18%)
Lexaria Expands COVID-19 Drug Research Program Utilizing Proprietary DehydraTECH

Remdesivir is one of several drugs to be evaluated KELOWNA, BC / ACCESSWIRE / December 22, 2020 / Lexaria Bioscience Corp. (OTCQX:LXRP)(CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug...

LXRP : 0.2249 (-10.68%)
LXX.CN : 8.400 (-1.18%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 0.2886
2nd Resistance Point 0.2713
1st Resistance Point 0.2481
Last Price 0.2249
1st Support Level 0.2076
2nd Support Level 0.1903
3rd Support Level 0.1671

See More

52-Week High 0.5600
Fibonacci 61.8% 0.4110
Fibonacci 50% 0.3650
Fibonacci 38.2% 0.3190
Last Price 0.2249
52-Week Low 0.1700

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar